Public Health Trace

Get Alerts

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to October 2026.

37,326

Total recall recordsAll FDA and USDA recalls in Public Health Trace

9,859

Class I recallsReasonable probability of serious health consequences

24,440

Class II recallsTemporary or medically reversible health consequences

2,900

Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls

Most common hazardLack of Assurance of Sterility 2,095 recalls

Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/winco-foods-llc-issues-allergy-alert-undeclared-sesame-hoagie-rollsPublished October 22, 2026

Most affected stateHawaii 200 recalls mention this state

State: OK ×
Clear all

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters

Timeline Classification Table

Metric

Time range

Group by

View

Recalls announced by month (Year to date)

Download CSV

Source: FDA and USDA public dataLast updated October 24, 2026 ET

Summary (Year to date)

1,739 recalls have been announced year to date.
Sep 2026 was 15% higher than the previous complete period (Aug 2026: 182).
The highest complete period was Jun 2026 (300).
Oct 2026 is incomplete and not included in the figures above.

Complete data
Incomplete

Recalls by class

Recalls by class
Class	Recalls
Class II	24,440
Class I	9,859
Class III	2,900
Not Yet Classified	2

Recalls by class
Class	Recalls
Class II	24,440
Class I	9,859
Class III	2,900
Not Yet Classified	2

FDA Recall TerminatedTerminated: September 28, 2023Historical recordClass III

Lidocaine Hydrochloride Oral Topical Solution, USP (Viscous) 2%, 100 mL per bottle, Rx only, Manufactured by Hi-Tech Pharmacal Co., Inc. Amityville, NY 11701, NDC 50383-775-04

by Akorn, Inc.

Reason: Failed viscosity specification - product was below specificcation
Published: May 11, 2022
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 21, 2023Historical recordClass II

alprazolam XR extended-release tablets, 3 mg, 60-count bottle, Rx only, Distributed by: Greenstone LLC, Peapack, NJ 07977, NDC 59762-0068-1.

by Viatris Inc

Reason: Failed Dissolution Specifications: low out-of-specification dissolution test results observed.
Published: May 11, 2022
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: May 22, 2023Historical recordClass II

Losartan Potassium and Hydrochlorothiazide Tablets USP, 100 mg/12.5 mg a) 30-count bottles (NDC# 68180-216-06) b) 90-count bottles (NDC# 68180-216-09), Rx Only, Manufactured By: Lupin Limited, Pithampur, India, MFG For: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, USA

by Lupin Pharmaceuticals Inc.

Reason: CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Published: May 11, 2022
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: May 22, 2023Historical recordClass II

Losartan Potassium and Hydrochlorothiazide Tablets USP, 100 mg/25 mg a) 30-count bottles (NDC# 68180-217-06) b) 90-count bottles (NDC# 68180-217-09), Rx Only, Manufactured By: Lupin Limited, Pithampur, India, MFG For: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, USA

by Lupin Pharmaceuticals Inc.

Reason: CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Published: May 11, 2022
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: May 22, 2023Historical recordClass II

Losartan Potassium and Hydrochlorothiazide Tablets USP, 50 mg/12.5 mg a) 30-count bottles (NDC# 68180-215-06) b) 90-count bottles (NDC# 68180-215-09), Rx Only, Manufactured By: Lupin Limited, Pithampur, India, MFG For: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, USA.

by Lupin Pharmaceuticals Inc.

Reason: CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Published: May 11, 2022
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: May 22, 2023Historical recordClass II

Losartan Potassium Tablets USP, 100 mg, a) 90-count bottles (NDC# 68180-378-03), b) 1000-count bottles (NDC# 68180-378-09), Rx Only, Manufactured By: Lupin Limited, Pithampur, India, MFG For: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, USA.

by Lupin Pharmaceuticals Inc.

Reason: CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Published: May 11, 2022
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: May 22, 2023Historical recordClass II

Losartan Potassium Tablets USP, 50 mg, a) 90-count bottles (NDC# 68180-377-03), b) 1000-count bottles (NDC# 68180-377-09), Rx Only, Manufactured By: Lupin Limited, Pithampur, India, MFG For: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, USA.

by Lupin Pharmaceuticals Inc.

Reason: CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Published: May 11, 2022
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: May 22, 2023Historical recordClass II

Losartan Potassium Tablets USP, 25 mg, a) 90-count bottles (NDC# 68180-376-03), b) 1000-count bottles (NDC# 68180-376-09), Rx Only, Manufactured By: Lupin Limited, Pithampur, India, MFG For: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, USA.

by Lupin Pharmaceuticals Inc.

Reason: CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Published: May 11, 2022
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: October 13, 2023Historical recordClass II

Losartan Potassium & Hydrochlorothiazide Tablets, USP, 100 mg/12.5 mg, a) 30-count bottles (NDC# 33342-051-07), b) 90-count bottles (NDC # 33342-051-10) c) 1000-count bottles (NDC # 33342-051-44), Rx Only, MFR: Macleods Pharma USA, Inc. Plainsboro, NJ 08536

by Macleods Pharma Usa Inc

Reason: CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Published: May 11, 2022
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: October 13, 2023Historical recordClass II

Losartan Potassium & Hydrochlorothiazide Tablets, USP, 100 mg/25 mg, a) 30-count bottles (NDC# 33342-052-07), b) 90-count bottles (NDC # 33342-052-10) c) 1000-count bottles (NDC # 33342-052-44), Rx Only, MFR: Macleods Pharma USA, Inc. Plainsboro, NJ 08536

by Macleods Pharma Usa Inc

Reason: CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Published: May 11, 2022
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: October 13, 2023Historical recordClass II

Losartan Potassium & Hydrochlorothiazide Tablets, USP, 50 mg/12.5 mg, a) 30-count bottles (NDC# 33342-050-07), b) 90-count bottles (NDC # 33342-050-10) c) 1000-count bottles (NDC # 33342-050-44), Rx Only, MFR: Macleods Pharma USA, Inc. Plainsboro, NJ 08536

by Macleods Pharma Usa Inc

Reason: CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Published: May 11, 2022
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: October 13, 2023Historical recordClass II

Losartan Potassium Tablets, USP, 100 mg, a) 30-count bottles (NDC # 33342-046-07), b) 90-count bottles (NDC # 33342-046-10), c) 1000-count bottles (NDC # 33342-046-44), Rx Only, MFR: Macleods Pharma USA, Inc. Plainsboro, NJ 08536

by Macleods Pharma Usa Inc

Reason: CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Published: May 11, 2022
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: October 13, 2023Historical recordClass II

Losartan Potassium Tablets, USP, 50 mg, a) 30-count bottles (NDC # 33342-045-07), b) 90-count bottles (NDC # 33342-045-10), c) 1000-count bottles (NDC # 33342-045-44), Rx Only, MFR: Macleods Pharma USA, Inc. Plainsboro, NJ 08536

by Macleods Pharma Usa Inc

Reason: CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Published: May 11, 2022
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: October 13, 2023Historical recordClass II

Losartan Potassium Tablets, USP, 25 mg, a) 90-count bottles (NDC # 33342-044-10), b) 1000-count bottles (NDC # 33342-044-44), Rx Only, MFR: Macleods Pharma USA, Inc. Plainsboro, NJ 08536

by Macleods Pharma Usa Inc

Reason: CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Published: May 11, 2022
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: September 9, 2022Historical recordClass II

Vancomycin HCl 1.5 g in 0.9% Sodium Chloride, 500 mL bags, Rx only, SCA Pharmaceuticals Windsor, CT 06095, NDC 70004-0924-44

by SCA Pharmaceuticals

Reason: CGMP Deviations
Published: May 11, 2022
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: September 9, 2022Historical recordClass II

Fentanyl 2mcg/ml and Bupivacaine 0.125% in 0.9% Sodium Chloride 100 mL bags, Rx only, SCA Pharmaceuticals Windsor, CT 06095, NDC 70004-0231-32

by SCA Pharmaceuticals

Reason: CGMP Deviations
Published: May 11, 2022
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: September 9, 2022Historical recordClass II

Norepinephrine 8mg in 0.9% Sodium Chloride 250 mL bag, Rx only, SCA Pharmaceuticals Windsor, CT 06095, NDC 70004-078-40

by SCA Pharmaceuticals

Reason: CGMP Deviations
Published: May 11, 2022
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: October 18, 2023Historical recordClass I

Insulin Glargine (insulin glargine-yfgn) Injection, 100 units/mL (U-100), packaged in a 10 mL Multiple-Dose vial inside a carton, Rx only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV 26505, Manufactured for: Mylan Specialty L.P., Morgantown, WV 26505, NDC 49502-393-80

by MYLAN PHARMACEUTICALS INC

Reason: Labeling: Missing label on the vial
Published: May 4, 2022
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 17, 2024Historical recordClass II

NAD+ Nicotinamide Adenine Dinucleotide Lyophilized powder for reconstitution, Multi-Dose 500 mg Per Vial, Rx Only, Olympia Pharmaceuticals 6700 Conroy Rd., Ste. 155, Orlando, FL 32835. NDC 73198-0083-00

by Olympia Compounding Pharmacy dba Olympia Pharmacy

Reason: Failed Reconstitution time
Published: May 4, 2022
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 17, 2024Historical recordClass II

Sincalide. Lyophilized powder for reconstitution. 5 mcg per Multi-Dose vial, Rx Only, Olympia Pharmaceuticals 6700 Convoy Rd., Ste. 155, Orlando, FL 32835. NDC 73198-0082-00.

by Olympia Compounding Pharmacy dba Olympia Pharmacy

Reason: CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated
Published: May 4, 2022
Distribution: Nationwide

View recall →

Data last updated: October 24, 2026 ET

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.